These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30398013)

  • 21. Validation of the new classification criteria for systemic lupus erythematosus on a patient cohort from a national referral center: a retrospective study.
    Bakula M; Čikeš N; Anić B
    Croat Med J; 2019 Aug; 60(4):333-344. PubMed ID: 31483119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
    Brunner HI; Feldman BM; Urowitz MB; Gladman DD
    J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete Systemic Lupus Erythematosus: What Remains After Application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria?
    Lambers WM; Westra J; Jonkman MF; Bootsma H; de Leeuw K
    Arthritis Care Res (Hoboken); 2020 May; 72(5):607-614. PubMed ID: 30932354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.
    Broder A; Mowrey WB; Izmirly P; Costenbader KH
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):599-604. PubMed ID: 27390299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
    Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
    Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L; Leone V; Pilkington C; Tullus K; Rangaraj S; McDonagh JE; Gardner-Medwin J; Wilkinson N; Riley P; Tizard J; Armon K; Sinha MD; Ioannou Y; Archer N; Bailey K; Davidson J; Baildam EM; Cleary G; McCann LJ; Beresford MW;
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus.
    Bernatsky S; Clarke A; Abrahamowicz M; Neville C; Karp I; Pineau CA
    J Rheumatol; 2005 May; 32(5):820-3. PubMed ID: 15868615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus.
    Li M; Zhang W; Leng X; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Zhang F; Zhao Y; Zeng X;
    Lupus; 2013 Oct; 22(11):1192-9. PubMed ID: 23963101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term mortality and morbidity of patients with systemic lupus erythematosus: a single-center cohort study in China.
    Wang Z; Li M; Wang Y; Xu D; Wang Q; Zhang S; Zhao J; Su J; Wu Q; Shi Q; Leng X; Zhang W; Tian X; Zhao Y; Zeng X
    Lupus; 2018 Apr; 27(5):864-869. PubMed ID: 29308727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    Legge A; Doucette S; Hanly JG
    J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determinant Factors of Morbidity in Patients with Systemic Lupus Erythematosus].
    Jacinto M; Silva E; Riso N; Moraes-Fontes MF
    Acta Med Port; 2017 May; 30(5):368-372. PubMed ID: 28865500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort.
    Hao Y; Oon S; Ji L; Gao D; Fan Y; Geng Y; Zhang X; Li G; Morand EF; Nikpour M; Zhang Z
    Clin Rheumatol; 2022 Feb; 41(2):357-366. PubMed ID: 34595670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P; Taechakraichana N; Osiri M
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus Erythematosus.
    Sharma C; Raymond W; Eilertsen G; Nossent J
    Arthritis Care Res (Hoboken); 2020 Mar; 72(3):447-451. PubMed ID: 30821926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity.
    Babaoğlu H; Li J; Goldman D; Magder LS; Petri M
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):225-232. PubMed ID: 31507071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study.
    Sag E; Tartaglione A; Batu ED; Ravelli A; Khalil SM; Marks SD; Ozen S
    Clin Exp Rheumatol; 2014; 32(3):440-4. PubMed ID: 24642380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.
    Petri M; Magder LS
    Arthritis Rheumatol; 2018 Nov; 70(11):1790-1795. PubMed ID: 29806142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW; Bultink IE; Heslinga M; Voskuyl AE
    Rheumatology (Oxford); 2017 Jan; 56(1):121-128. PubMed ID: 27803306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.